The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

Abstract

In this retrospective cohort of PCa patients, the use of ADT was not demonstrated to influence severe COVID-19 outcomes, as defined by hospitalization, supplemental oxygen use, or death. Age 70 years and older was statistically significantly associated with a higher risk of developing severe COVID-19 disease.